J Metab Bariatr Surg.
2022 Dec;11(2):13-19. 10.17476/jmbs.2022.11.2.13.
Changes of Guidelines in the Management of Obese Patients With Diabetes in the Metabolic Surgery Perspective
- Affiliations
-
- 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea
- 2Department of Surgery, Kosin University College of Medicine, Busan, Korea
- KMID: 2552775
- DOI: http://doi.org/10.17476/jmbs.2022.11.2.13
Abstract
- Recently, metabolic surgery was recommended for patients with a BMI of 30 or higher and 27.5 or higher for Asians, as evidence level A. Until 2008, bariatric surgery was not introduced for the treatment of diabetes. Bariatric surgery was first recommended for adults with body mass index ≥35 kg/m 2 and type 2 diabetes in the American Diabetes Association (ADA) guidelines as evidence level B in 2009. In 2017, the terminology was changed from bariatric surgery to metabolic surgery. How such large changes could have occurred in the ADA guidelines? Because many patients have reached diabetes remission through metabolic surgery, and the long-term benefit and cost-effectiveness have been strongly proven by historical randomized controlled trials and high-quality studies. This review demonstrates how the recommendations for the treatment of obesity in patients with diabetes have changed in diabetes treatment guidelines and summarizes the evidence behind this change.
